GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » ROC %

MeVis Medical Solutions AG (XTER:M3V) ROC % : 24.11% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. MeVis Medical Solutions AG's annualized return on capital (ROC %) for the quarter that ended in Mar. 2024 was 24.11%.

As of today (2024-06-19), MeVis Medical Solutions AG's WACC % is 3.16%. MeVis Medical Solutions AG's ROC % is 25.09% (calculated using TTM income statement data). MeVis Medical Solutions AG generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


MeVis Medical Solutions AG ROC % Historical Data

The historical data trend for MeVis Medical Solutions AG's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG ROC % Chart

MeVis Medical Solutions AG Annual Data
Trend Dec13 Dec14 Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.87 32.03 26.88 34.93 26.23

MeVis Medical Solutions AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.91 37.13 25.57 26.22 24.11

MeVis Medical Solutions AG ROC % Calculation

MeVis Medical Solutions AG's annualized Return on Capital (ROC %) for the fiscal year that ended in Sep. 2023 is calculated as:

ROC % (A: Sep. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Sep. 2022 ) + Invested Capital (A: Sep. 2023 ))/ count )
=4.905 * ( 1 - 2.26% )/( (18.217 + 18.343)/ 2 )
=4.794147/18.28
=26.23 %

where

MeVis Medical Solutions AG's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=4.594 * ( 1 - 2.71% )/( (18.343 + 18.734)/ 2 )
=4.4695026/18.5385
=24.11 %

where

Note: The Operating Income data used here is two times the semi-annual (Mar. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MeVis Medical Solutions AG  (XTER:M3V) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, MeVis Medical Solutions AG's WACC % is 3.16%. MeVis Medical Solutions AG's ROC % is 25.09% (calculated using TTM income statement data). MeVis Medical Solutions AG generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


MeVis Medical Solutions AG ROC % Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


MeVis Medical Solutions AG (XTER:M3V) Business Description

Traded in Other Exchanges
Address
Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines